Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells

Overview of attention for article published in BMC Pharmacology, June 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

patent: 1 patent

wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 17 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

1‐[2‐(1‐Cyclobutylpiperidin‐4‐yloxy)‐6,7‐dihydro‐4H‐thiazolo[5,4‐c]pyridin‐5‐yl]propan‐1‐one: a Histamine H3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition

Article in ChemMedChem (November 2021)

Early Diagnosis of Cerebral Ischemia Reperfusion Injury and Revelation of Its Regional Development by a H3R Receptor-Directed Probe

Article in ACS Sensors (March 2021)

Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation

Article in Psychopharmacology (February 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.